POTS Treatment Without Medication: Why Drugs Suppress the Compensation Your Brain Needs

If you have POTS, you have almost certainly been offered medication. Beta blockers to slow the heart rate. Midodrine to raise blood pressure. Fludrocortisone to expand blood volume. Maybe ivabradine if the beta blocker side effects were too much. Your doctor saw a number that was too high and prescribed something to make it lower.

And maybe it helped. Genuinely helped. The pounding heart settled down. The anxiety-like sensations backed off enough that you could get through the day. That relief is real, and it matters. Nobody should feel bad about using whatever tools have kept them functional.

But you are still here. Still searching. Still symptomatic. The heart rate came down some, but the brain fog stayed. The fatigue stayed. The feeling of being unable to do normal things — grocery shopping, cooking dinner, standing long enough to have a conversation — that stayed too.

This is not an anti-medication argument. This is a mechanism argument. When you understand what the tachycardia is actually doing and why it exists, the logic of relying on medication alone starts to show its limits.

Why POTS Tachycardia Is a Compensation, Not the Disease

Your heart has an intrinsic firing rate of approximately 100–120 beats per minute — that is what it does on its own, with no autonomic input. Jose and Collison established this in 1970 using complete pharmacological autonomic blockade (Jose & Collison, Cardiovasc Res, 1970). At rest, the brain holds the rate down. When you stand and cerebral blood flow drops, the heart does the one thing it can do quickly: beat faster to push more blood upward against gravity.

That is not a malfunction. That is an intelligent compensation for a real problem. The heart rate is usually not the main problem — it is the compensation for the problem. The tachycardia is the most valuable tool the body has in response to whatever the underlying issue is.

Now think about what a beta blocker does. It takes away that tool. It clamps down the heart rate without fixing the reason the heart rate needed to be elevated. The brain was trying to maintain perfusion. You just told it to stop.

Where Each Medication Helps — and Where It Stops

This is not about which medication is "bad." Each one does something real. The question is whether what it does is enough.

Each medication substitutes for a function the body should be performing on its own. The vestibulo-sympathetic reflex adjusts vascular tone within 50–100 milliseconds of a position change (Yates et al., Compr Physiol, 2014). Midodrine does it chemically, from the outside, with no dynamic adjustment. The renin-aldosterone system should regulate blood volume automatically. Fludrocortisone overrides that signal. In each case, the external override prevents the system from being challenged to regulate on its own — so it never recalibrates. The patient stays dependent on the medication, managing a symptom, while the regulation failure persists underneath.

Some patients feel weaker on beta blockers. More lethargic. Foggier. That is not always a "side effect" in the traditional sense — it can be the body telling you it needed that compensation. When the heart rate was elevated, it was maintaining enough cerebral perfusion to keep you somewhat functional. Suppress that, and perfusion may drop further. Research bears this out: 90% of 429 ME/CFS patients showed abnormal cerebral blood flow reduction during tilt, even when heart rate and blood pressure appeared normal (van Campen et al., Clin Neurophysiol Pract, 2020). If cerebral perfusion is already compromised, removing the heart rate compensation can make the brain's situation worse.

What the Head-to-Head Research Shows

The only randomized controlled trial directly comparing a medication to a non-pharmacological intervention in POTS tells a clear story. Fu et al. randomized POTS patients to propranolol or exercise training. Exercise was superior on every measured outcome — upright hemodynamics, renal-adrenal responsiveness, and quality of life. 53% of patients who completed exercise training no longer met POTS diagnostic criteria. Propranolol did not improve quality of life (Fu et al., Hypertension, 2011).

A larger pragmatic trial confirmed the pattern: after 6 months, only 23% of the exercise group still met heart rate criteria for POTS vs 93% of controls (George et al., Heart Rhythm, 2021).

But there is an important nuance. Those exercise trials used a standardized cardiovascular protocol — the Levine or CHOP approach. One size fits all. Recumbent exercise progressing to upright over months. It works for some. In community settings, roughly half of patients dropped out before completing the program (Galbreath et al., Heart Rhythm, 2016). The dropout rate tells you the protocol does not match a lot of people's physiology. The exercise is not the problem. The dose is.

Salt, Fluids, and Compression Are Management

When people search for "POTS treatment without medication," the standard advice is: increase salt intake, drink more fluids, wear compression garments. These are not medications, true. But they are not treatment either. They are management strategies.

Salt and fluids expand blood volume. Compression garments reduce venous pooling in the legs. Both help in the short term. Neither one addresses why the regulation system failed to distribute blood effectively. Neither one restores the neurological coordination that should be handling this automatically. Management keeps you functional within the constraints of the dysfunction. Treatment removes the dysfunction so the constraints no longer exist.

There is a place for management — especially early on, while the regulation system is being rehabilitated. But management alone is a holding pattern, not a destination.

What Treatment Without Medication Actually Means

Real POTS treatment without medication is not about avoiding drugs for the sake of it. It is about addressing what medications cannot reach: the regulation failure itself.

The brain orchestrates the entire postural response through pathways at every level of the central nervous system. When you stand, the brainstem integrates data from vestibular organs, cervical proprioceptors, baroreceptors, and respiratory centers — among others — and coordinates a cardiovascular response in real time. The system has extraordinary depth. There are tracts, nuclei, and processing nodes involved at every level from the spinal cord to the cortex. Disruption at any point in that chain can produce the same downstream picture: symptoms that get labeled POTS.

The question is not "medication or no medication." It is: are you treating the compensation, or are you treating the regulation failure that made the compensation necessary?

Identifying the regulation failure requires measuring where it matters. Transcranial Doppler shows whether blood is reaching the brain during orthostatic challenge. Capnography reveals whether CO2-driven vasoconstriction is silently reducing cerebral perfusion. Del Pozzi et al. showed that the drop in cerebral blood flow precedes the hyperventilation by approximately 17 seconds (Del Pozzi et al., Hypertension, 2014) — meaning the breathing changes are a consequence of the hemodynamic failure, not its cause. Baker et al. confirmed in 2024 that reduced brain perfusion itself drives the respiratory and sympathetic activation (Baker et al., JACC Basic Transl Sci, 2024).

Breathing pattern disorders are not rare in this population. Reilly et al. found that 84% of 100 POTS patients had measurable dysfunctional breathing on formal assessment (Reilly et al., Auton Neurosci, 2020). And Stewart demonstrated that restoring CO2 levels via rebreathing in a hyperventilating POTS subgroup normalized heart rate, blood pressure, cardiac output, and systemic vascular resistance to control values (Stewart et al., JAHA, 2018). Fix the gas exchange, and the downstream numbers correct themselves.

How Neurological Rehabilitation Recalibrates the Regulation Failure

Once the specific regulation failure is identified, targeted rehabilitation challenges the circuits that have degraded. This is not a one-size-fits-all exercise prescription. Each component of rehabilitation targets a different input to the postural response, based on what the evaluation reveals.

Vestibular rehabilitation retrains the balance system's input to the brainstem — dosed to current capacity, because the nervous system has thresholds. Too much stimulus overwhelms a system that is already struggling. Oculomotor retraining drives activity in brainstem circuits that overlap with autonomic control centers. Cervical proprioceptive work restores accurate positional data flowing from the spine to the brainstem — and a randomized controlled trial confirmed that restoring cervical alignment produced significant normalization of autonomic function maintained at long-term follow-up (Moustafa et al., J Athl Train, 2021). Central respiratory integration retraining addresses hypocapnic vasoconstriction by restoring the brainstem's ability to regulate breathing automatically — not through willpower, but by recalibrating the system so it automates properly again.

Exercise is dosed to cerebral blood flow data. When we have transcranial Doppler data, we know exactly how much hemodynamic stress the brain can currently tolerate. Right dose, right time, right progression — that is how patients who could not walk around the block begin rebuilding capacity without crashing.

The brain's capacity to change is not theoretical. The Nobel laureate Eric Kandel demonstrated that repeated, specific stimulation physically changes synaptic structure — growing new synaptic terminals that persist over time (Kandel, Science, 2001). That capacity does not disappear because you have POTS. When you challenge the specific circuits that have degraded — at the right intensity, targeting the right pathways — those circuits recalibrate. The postural response improves. Energy expenditure drops toward normal. The heart rate normalizes because the system no longer needs to compensate.

That is the difference between suppression and recalibration. Suppression manages a broken system. Recalibration rebuilds it.

Where Medication Fits

Not every patient needs to stop medication to begin rehabilitation. Some patients have severe enough symptoms that the pharmacological support — imperfect as it is — is keeping them functional enough to participate in treatment. Medications can serve as a bridge while the regulation system is being rebuilt.

The goal is not to rip away something that is helping. The goal is to restore enough regulation that the body no longer needs as much pharmacological support. Many patients continue their medications throughout rehabilitation, adjusting as function improves. The question at every stage is the same: is this medication supporting recovery, or is it substituting for a system that should be challenged to work on its own?

The patients who benefit most from this approach are often the ones who have been on medications long enough to recognize the ceiling. The medications took the edge off, but life did not actually improve. Function did not return. The question "is this as good as it gets?" is the one that leads to looking for something different.

Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Medication decisions should be made with your prescribing physician.

← Back to Blog